MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avila, A.
Right arrow Articles by Moscat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avila, A.
Right arrow Articles by Moscat, J.

 Previous Article

Molecular and Cellular Biology, December 2002, p. 8787-8795, Vol. 22, No. 24
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.24.8787-8795.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

The Drosophila Atypical Protein Kinase C-Ref(2)P Complex Constitutes a Conserved Module for Signaling in the Toll Pathway

Antonia Avila,1 Neal Silverman,2 María T. Diaz-Meco,1 and Jorge Moscat1*

Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma, Canto Blanco, 28049 Madrid, Spain,1 Department of Medicine, Division of Infectious Disease and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts 016552

Received 12 April 2002/ Returned for modification 17 June 2002/ Accepted 11 September 2002


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Recent results showed the critical role of the mammalian p62-atypical protein kinase C (aPKC) complex in the activation of NF-{kappa}B in response to different stimuli. Here we demonstrate using the RNA interference technique on Schneider cells that the Drosophila aPKC (DaPKC) is required for the stimulation of the Toll-signaling pathway, which activates the NF-{kappa}B homologues Dif and Dorsal. However, DaPKC does not appear to be important for the other Drosophila NF-{kappa}B signaling cascade, which activates the NF-{kappa}B homologue Relish in response to lipopolysaccharides. Interestingly, DaPKC functions downstream of the nuclear translocation of Dorsal or Dif, controlling the transcriptional activity of the Drosomycin promoter. We also show that the Drosophila Ref(2)P protein is the homologue of mammalian p62 as it binds to DaPKC, its overexpression is sufficient to activate the Drosomycin but not the Attacin promoter, and its depletion severely impairs Toll signaling. Collectively, these results demonstrate the conservation of the p62-aPKC complex for the control of innate immunity signal transduction in Drosophila melanogaster.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
The atypical protein kinase C (aPKC) subfamily is composed of two members: {zeta}PKC and {lambda}/{iota}PKC. These isoforms are characterized by their insensitivity to classical PKC activators, such as diacylglycerol and Ca2+, in contrast to the more typical PKCs, which contain motifs in their regulatory domains that make them targets for those second messengers (25). Both aPKCs have been shown to be involved in several cellular functions, including growth and survival, as well as in the establishment and maintenance of epithelial cell polarity (24). These kinases have also been implicated in the regulation of NF-{kappa}B, where they are thought to be essential in the regulation of the phosphorylation of the RelA subunit of this transcription factor (20, 24). The mechanism by which the aPKCs can regulate these different signaling pathways is not completely clear. However, the existence of scaffold proteins may explain how a single PKC subtype can be involved in different signaling cascades. Thus, through their interaction with p62, the aPKCs are located in the NF-{kappa}B pathway (28-30), while their binding to MEK5 (7) may serve to place the aPKCs in the BMK1/ERK5 mitogenic signaling cascade that likely regulates c-Jun expression. In addition, the interaction with Par-6/ASIP involves the aPKCs in the control of cell polarity. p62, Par-6, and MEK5 harbor in their respective amino-terminal regions a small sequence of acidic amino acids, termed AID (for aPKC interaction domain), that is required for the interaction of these adapters with the aPKCs (24). The AID region is a subtype of the OPCA motif, which groups AID-related sequences, such as the octicosapeptide repeat and the Phox and CDC motifs (PC) (26). The Drosophila homologue of Par-6 has been identified, which indicates that the Par-6-aPKC cassette is also conserved in flies (16, 22, 27, 37, 40). Interestingly, the Drosophila orthologue of p62 has not been investigated yet.

The role of the aPKCs in the NF-{kappa}B pathway has been established by using different and independent strategies, such as the microinjection of inhibitor peptides, the use of antisense oligonucleotides, and the transfection of dominant negative mutants (24). Recent results from this laboratory demonstrate that embryonic fibroblasts from {zeta}PKC-/- mice show impairment in the NF-{kappa}B pathway, which affects the ability of this factor to activate transcription (20). This finding demonstrates an essential and nonredundant role of {zeta}PKC in this important cascade, which cannot be compensated for by the presence of the other aPKC isoform, {lambda}/{iota}PKC.

Drosophila melanogaster encodes only one aPKC (DaPKC), making it a simpler system for investigation of the role of aPKC in different signaling pathways. Also, studies using Drosophila cell cultures are particularly powerful because the use of the RNA interference technique (RNAi) has proven to be an efficient way to selectively deplete cells of signal transduction proteins. In particular, Drosophila cell culture is an excellent system to investigate the immune signaling pathways which activate the Drosophila NF-{kappa}B homologues, as there is a remarkable degree of homology with mammalian systems (33). For example, Dorsal and Dif, the Drosophila homologues of RelA, have been shown to play a critical role in the control of innate immunity and Dorsal also plays a role in early embryonic patterning (14, 33). Both Dorsal and Dif are retained in the cytosol by the I{kappa}B homologue Cactus, whose phosphorylation and subsequent degradation release both transcription factors from the cytosolic complex, allowing them to translocate to the nucleus (10, 33). The identity of the kinase responsible for the phosphorylation of Cactus is still unclear, but it has been well established that this event depends on the kinase Pelle, which is similar to interleukin-1 receptor-associated kinase (IRAK), a critical component of the interleukin-1-NF-{kappa}B signaling pathway (14, 33). Through the adapter Tube and the Drosophila homologue of MyD88 (12, 38), Pelle links Cactus degradation to the Toll receptor signaling pathway in Drosophila (33). In mammals, IRAK binds TRAF6, which in turn is responsible for NF-{kappa}B and Jun kinase (JNK) activation (4, 23). The Drosophila homologue of TRAF6 may be DTRAF2, which has recently been implicated in the activation of the Dorsal pathway (32).

Parallel to Toll signaling another cascade is critical for the insect immune response. This pathway requires a different Rel family member, Relish, which is the fly homologue of p100/p105 (9, 18, 34, 36). The mechanism of activation of this Rel protein is different from that of classical RelA/p50 in mammals and those of Dorsal and Dif in Drosophila. Relish is composed of an N-terminal Rel homology domain followed by a C-terminal I{kappa}B-like sequence; its endoproteolytic cleavage is triggered by an I{kappa}B kinase (IKK) enzymatic activity similar to that of the mammalian signalsome complex responsible for the phosphorylation of I{kappa}B and p100 (34). This Relish pathway is activated by infection by gram-negative bacteria or lipopolysaccharide (LPS) treatment, while the Toll pathway is more critical for immunity to fungi and gram-positivie bacteria (33).

In this study, we sought to determine whether DaPKC plays a role in either of the two Drosophila NF-{kappa}B cascades, as well as whether the p62-aPKC cassette is conserved in this organism.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Reagents and cell culture. S2 cells were purchased from Invitrogen. S2tpll cells are stable clones engineered to assay the Toll pathway by Cu2+ addition (34). Cells were grown at 25°C in Schneider medium (Gibco BRL) supplemented with 10% inactivated fetal calf serum. The monoclonal 12CA5 anti-hemagglutinin (HA) and anti-Flag antibodies were from Boehringer and Sigma, respectively. The rabbit anti-aPKC (C-20) and anti-Myc were from Santa Cruz Biotechnologies. The Dorsal and the Cactus monoclonal antibodies were a gift from Ruth Steward. The Relish antibody was the anti-C described previously (9, 36).

Plasmids. The templates for the RNAi experiments were constructed by cloning the first 600 bp of Drosophila aPKC and the first 300 bp of the Ref(2)P coding regions in pGEMT vectors (Promega). The luciferase reporter constructs with the Drosomycin and Attacin promoters were a generous gift from J. M Imler and were described previously (38). For expression in insect cells, the Myc-Ref(2)P plasmid was constructed by isolating S2 cDNA by reverse transcription and subcloning it into the inducible plasmid pMT/V5 (Invitrogen); the Drosophila aPKC cDNA was subcloned into the same vector. The human {iota}PKC cDNA was subcloned into the pPAC vector. HA-DTRAF2 was a generous gift from J. L. Manley (32). For expression in mammalian 293 cells, Myc-Ref(2)P, HA-Ref(2)P, and Flag-TRAF2 were constructed by subcloning the coding sequences into the pCDNA3 vector (Invitrogen).

RNAi. The RNAs of aPKC and Ref(2)P were synthesized with the SP6 and T7 RiboMAX RNA production system (Promega). The RNA single strands were hybridized by heating them for 30 min at 65°C and then cooling them slowly to room temperature. S2 or S2tpll cells were plated 1 day before transfection by the calcium phosphate precipitation technique, with 15 µg of double-stranded RNA (dsRNA) in a mix with a total of 50 µg of DNA and RNA per each 9 x 106 cells. The next day, cells were washed four times with phosphate-buffered saline (PBS) and ecdysone was added to a final concentration of 1 µM.

Luciferase reporter assays. Cells were seeded in six-well plates 1 day before transfection, and then they were transfected with 0.5 µg of reporter plasmid and 2 µg of dsRNA. For the DTRAF2 and Ref(2)P expression experiments, an additional 1 to 3 µg of expression plasmids was added. The total amount of RNA and DNA per well was adjusted to 8 µg, and a Renilla reporter was used as a control. All transfections were done in triplicate. Cells were induced with copper sulfate to a final concentration of 500 µM for either 12 h to express HA-Ref(2)P or 1 to 5 h to induce the Toll pathway. Then cells were harvested and washed twice with PBS, and the luciferase and Renilla activities were determined by the Dual-Luciferase reporter assay from Promega.

Coimmunoprecipitations and Western blot analyses. For immunoprecipitations, transfected 293 or S2 cells were lysed in PD buffer (40 mM Tris-HCl [pH 8], 500 mM NaCl, 0.1% NP-40, 6 mM EDTA, 6 mM EGTA, 10 mM ß-glycerophosphate, 10 mM NaF, 10 mM phenylphosphate, 300 µM Na3VO4, 1 mM benzamidine, 2 M phenylmethylsulfonyl fluoride, 10 µg of aprotinin/ml, 1 µg of leupeptin/ml, 1 µg of pepstatin/ml, 1 mM dithiothreitol) and incubated with protein A or protein G beads for 2 h. Clarified lysates were incubated overnight with the appropriate antibody (anti-HA antibody, a monoclonal anti-Flag antibody, or a polyclonal anti-{zeta}PKC antibody). The immune complexes were recovered by the addition of protein A or G beads. After extensive washing, beads were boiled and resolved on 8% polyacrylamide gels. Proteins were transferred onto poly(vinylidene fluoride) membranes by electroblotting and then probed with the corresponding antibody. The membrane localization of {zeta}PKC in Ref(2)P RNAi-treated cells was determined as described previously (28).

Cytosolic and nuclear fractionation. About 9 x 106 transfected cells were harvested, washed twice with PBS, and incubated for 5 min at 4°C in 1 ml of buffer A (10 mM HEPES [pH 8], 50 mM NaCl, 0.5 M sucrose, 1 mM EDTA, 0.5 mM spermidine, 0.15 mM spermine, 0.5% Triton X-100, 7 mM ß-mercaptoethanol, and protease inhibitors). The lysate was spun, and the supernatant constituted the cytosolic fraction. The pellet was washed with buffer B (10 mM HEPES [pH 8], 50 mM NaCl, 0.1 mM EDTA, 0.5 mM spermidine, 0.15 mM spermine, 25% glycerol, 7 mM ß-mercaptoethanol, and protease inhibitors), incubated for 30 min at 4°C in 30 to 80 µl of buffer C (10 mM HEPES [pH 8], 350 mM NaCl, 0.1 mM EDTA, 0.5 mM spermidine, 0.15 mM spermine, 25% glycerol, 7 mM ß-mercaptoethanol, and protease inhibitors), and centrifuged for 15 min at maximum speed to obtain the nuclear fraction.

RT-PCRs. The total RNA was extracted from transfected S2 or S2tpll cells by using ULTRASPEC reagent according to the instructions of the manufacturer (Biotecx). The Drosomycin, Diptericin, Ref(2)P, and Dactin mRNA levels were determined by a single-step reverse transcription-PCR (RT-PCR) with the following oligonucleotides: for Drosomycin, 5'-CATTTACCAAGCTCCGTGAG-3' and 5'-GTAGTGGAGAGCTAAACGCG-3'; for Diptericin, 5'-GGCTTCAATTGAGAACAACTG-3' and 5'-CTAGACTCGGATACCAATCG-3'; for Ref(2)P, 5'-CCACAAGCTGAGCCCACTGTTACC-3' and 5'-TTGAATATGAATATTTAG TTGCGG-3'; and for Dactin, 5'-CGCTGAACCCCAAGGCCAAC-3' and 5'-TCATGATGGAGTTGTAGGTGGTCTC-3'. Thirty nanograms of total RNA was used as a template, and conditions were done in the linear range.

In vitro phosphorylation of Dif. Three micrograms of recombinant glutathione S-transferase (GST)-Dif was incubated at 30°C for 30 min in 20 µl of assay buffer containing 25 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 0.5 mM EGTA, 1 mM dithiothreitol, and 50 µM ATP in the presence of recombinant baculovirus-expressed {zeta}PKC (30 ng).


   RESULTS
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
The down-regulation of DaPKC selectively impairs the activation of the Toll pathway in Drosophila Schneider cells. In order to address the potential role of DaPKC in the Drosophila innate immunity system, we depleted DaPKC levels using RNAi in Schneider S2 cells that had been engineered to assay the Toll-signaling pathway (34). These cells had been stably transfected with a Torso-Pelle fusion construct controlled by the metallothionein promoter (S2tpll). This construct creates a constitutively active Pelle kinase that activates the Cactus/Dorsal and Cactus/Dif cascades upon its expression following the addition of Cu2+ to S2tpll cell cultures. To stimulate the Relish pathway, cells were treated with LPS. The activation of the Toll pathway was monitored by quantifying the induction of the antimicrobial peptide gene Drosomycin. The activation of the Relish cascade was determined by monitoring the induction of the antimicrobial peptide gene Diptericin. S2tpll cells were transfected with DaPKC dsRNA, which leads to a substantial reduction of the DaPKC protein levels (Fig. 1A). These cells were either stimulated with LPS or Cu2+ for 3 h or left unstimulated, and the transcriptional activation of Diptericin or Drosomycin, respectively, was determined by semiquantitative RT-PCR. Results shown in Fig. 1A demonstrate that the reduction of DaPKC levels leads to a severe inhibition of the torso-pelle-induced transcription of Drosomycin, with no effect on the LPS-mediated induction of Diptericin. The activation of Drosophila Jun kinase by the addition of Cu2+ to the S2tpll cells is not affected by the depletion of DaPKC levels (data not shown). These observations strongly suggest that DaPKC plays an essential and selective role in the Toll pathway. When the human aPKC {iota}PKC was transfected into cells treated with DaPKC dsRNA, the induction of Drosomycin was largely restored (Fig. 1B).



View larger version (39K):
[in this window]
[in a new window]
  		FIG. 1. DaPKC is essential for Drosomycin transcription. (A) S2tpll cells were transfected with DaPKC dsRNA (RNAi) or left untreated (Mock), after which they were stimulated with either Cu2+ (left panel) or LPS (right panel) and the transcriptional activation of Drosomycin (left panel) or Diptericin (right panel) was determined by RT-PCR. Dactin mRNA levels were also determined as a control for RNA loading. The levels of DaPKC were determined in parallel cell extracts by immunoblotting. The results shown are representative of results from at least two other experiments. (B) In another experiment, S2tpll cells that were transfected with DaPKC dsRNA were transfected with either the plasmid control, C, or an expression vector for human {iota}PKC, after which they were stimulated with Cu2+ and the transcriptional activation of Drosomycin was determined by RT-PCR. Dactin mRNA levels were also determined as a control for RNA loading. The lower panel, which shows the results of immunoblotting with an antibody that cross-reacts with both aPKCs, demonstrates the effective depletion of DaPKC and the expression of human {iota}PKC. Note that {iota}PKC runs faster than DaPKC in this gel.

 
Depletion of DaPKC does not affect Cactus or Relish degradation. The activation of the Toll pathway induces the degradation of Cactus. To determine whether DaPKC acts upstream or downstream of this step in the pathway, S2tpll cells transfected or not transfected with DaPKC dsRNA were induced to express the Torso-Pelle construct or were stimulated with LPS for 3 h and the degradation of Cactus and the cleavage of Relish were determined by immunoblot analysis of cell extracts. The expression of Torso-Pelle (Fig. 2), but not the addition of LPS (data not shown), provokes a reproducible degradation of Cactus which is not affected by the reduction in DaPKC levels (Fig. 2). Conversely, LPS addition (Fig. 2) but not Torso-Pelle expression (data not shown) promotes the cleavage of Relish, which is not affected by the reduction of DaPKC levels (Fig. 2). Collectively, these results indicate that DaPKC plays an essential role in the Toll-Dorsal/Dif immune pathway, acting downstream of Cactus degradation.



View larger version (26K):
[in this window]
[in a new window]
  		FIG. 2. DaPKC is not required for Cactus or Relish degradation. S2tpll cells were transfected with DaPKC dsRNA (RNAi) or not transfected (Mock) and stimulated as described above, after which the levels of Cactus (left panel), Relish (right panel), and DaPKC (both panels) were determined by immunoblotting with the corresponding antibodies. The results shown are representative of results from at least three other experiments.

 
Dorsal and Dif nuclear translocation in DaPKC-depleted cells. Upon the degradation of Cactus, Dif and Dorsal are released and translocate to the nucleus (33). To determine if the inhibition of Drosomycin transcription detected in the DaPKC-depleted cells could be accounted for by a decrease in Dorsal nuclear translocation, cells were treated as described above, after which they were fractionated and Dorsal levels in the nuclear fraction were determined. Results shown in Fig. 3A demonstrate that the lack of DaPKC has little effect on the accumulation of nuclear Dorsal in response to torso-pelle expression. To address whether the nuclear translocation of Dif could be affected by the depletion of DaPKC levels, S2tpll cells were transfected with a Flag-tagged Dif expression vector along with a plasmid for Cactus, whose expression impedes the unregulated nuclear translocation of Dif, with or without DaPKC dsRNA, after which cells were induced to express the Torso-Pelle construct and the nuclear translocation of Flag-Dif was determined. Interestingly, the depletion of DaPKC levels has little effect on the induced nuclear translocation of Dif (Fig. 3B).



View larger version (45K):
[in this window]
[in a new window]
  		FIG. 3. DaPKC is not required for the nuclear translocation of Dorsal or Dif. S2tpll cells were transfected (B) or not transfected (A) with a Flag-tagged Dif expression vector along with a Cactus plasmid with (RNAi) or without (Mock) DaPKC dsRNA, after which they were stimulated or not stimulated with Cu2+, and the levels of nuclear Dorsal (Dorsal-nuc) (A), cytosolic Dorsal (Dorsal-cyt) (A), nuclear Flag-Dif (Dif-nuc) (B), cytosolic Flag-Dif (Dif-cyt) (B), and total DaPKC (A and B) were determined by immunoblotting. The results shown are representative of results from at least three other experiments.

 
The down-regulation of DaPKC inhibits Drosomycin promoter transcriptional activity. The results obtained so far strongly suggest that DaPKC is required for the activation of Drosomycin transcription at a level that is downstream of Cactus and the translocation of Dorsal or Dif. In order to demonstrate that this is actually the case, S2tpII cells were transfected with a Drosomycin promoter luciferase reporter construct either with or without DaPKC dsRNA, after which cells were induced or not induced with Cu2+ and the luciferase activities were determined for all samples. Consistent with the RT-PCR results, the activation of the Drosomycin promoter by Torso-Pelle was severely inhibited by the down-regulation of DaPKC (Fig. 4). As a control, cells were transfected in parallel with a luciferase reporter construct under the control of the Attacin promoter that is selectively activated by LPS (38). In marked contrast to what occurred with the Drosomycin promoter, the down-regulation of DaPKC did not inhibit the transcriptional activity of the Attacin promoter activated by LPS (Fig. 4). This finding is in good agreement with the notion that DaPKC plays a selective and critical role in the Toll pathway in Drosophila cells.



View larger version (30K):
[in this window]
[in a new window]
  		FIG. 4. DaPKC is required for the activation of the Drosomycin promoter. S2tpll cells were (RNAi) or were not (Mock) transfected with DaPKC dsRNA along with either Drosomycin or Attacin luciferase reporter vectors, after which cells were stimulated (black bars) with Cu2+ (for the Drosomycin promoter) or LPS (for the Attacin promoter) or were left unstimulated (white bars), and the luciferase activities of cell extracts were determined. The results shown are representative of results from at least three other experiments. A representative immunoblot is shown for endogenous DaPKC.

 
Ref(2)P is critical for the activation of the Drosomycin promoter. Recent studies from this laboratory have implicated the aPKC adapter p62 in NF-{kappa}B activation in mammalian cells (29). p62 interacts physically and functionally with TRAF6, which is required for NF-{kappa}B activation in interleukin-1-stimulated cells (23). A search of the Flybase data bank reveals the existence of a potential orthologue of p62, named Ref(2)P, that has an overall structure similar to that of p62, including the AID sequence, a putative ZZ zinc finger, and a C-terminal ubiquitin-associated domain (Fig. 5). The overall similarity at the amino acid level between Ref(2)P and human p62 is 23.9%, and the identity is 17.9%. This is comparable to the overall homology between human TRAF6 and DTRAF2 (31.1% similarity and 21.9% identity) or between human MyD88 and DMyD88 (22.1% similarity and 14.3% identity). The exact function of Ref(2)P as well as its mechanism of action is still unclear, although earlier studies indicated that it may play a role in the normal replication of some strains of sigma virus (5, 6, 39, 42). Based on the role of p62 in mammalian cells and its homology with Ref(2)P, we sought to determine whether the overexpression of Ref(2)P was sufficient to activate the Drosomycin promoter. Thus, S2 cells were transfected with either the Drosomycin or the Attacin reporter constructs as described above, along with a plasmid control or increasing amounts of a Ref(2)P expression vector, and the luciferase activities were determined. Interestingly, the expression of Ref(2)P is sufficient to activate the Drosomycin but not the Attacin promoter (Fig. 6).



View larger version (32K):
[in this window]
[in a new window]
  		FIG. 5. Sequence and structure conservation between Ref(2)P and p62. (A) Schematic representation of Ref(2)P and p62 sequences. OPCA is the sequence with homology to the AID domain, ZnF (ZZ) is the atypical ZZ zinc finger domain, and UBA is the ubiquitin-associated domain. (B) Sequence alignments of the OPCA, ZnF, and UBA domains of Ref(2)P and p62 were done with the Clustal program.

 


View larger version (28K):
[in this window]
[in a new window]
  		FIG. 6. Ref(2)P expression activates the Drosomycin promoter. S2 cells were transfected with the Drosomycin (black bars) or the Attacin (white bars) luciferase reporter as described above, along with increasing amounts (1, 3, and 10 µg) of a Ref(2)P expression vector, and the luciferase (Luc.) activities of cell extracts were determined. Results are the means ± standard deviations (SD) of results from three independent experiments with duplicate incubations. A representative immunoblot for Ref(2)P that was subjected to the corresponding anti-tag antibody is shown below the graph.

 
The antisense-mediated depletion of p62 in mammalian cells leads to an inhibition of NF-{kappa}B activation in response to different stimuli (29, 41). In order to determine whether Ref(2)P is selectively required for the activation of the Drosomycin promoter, S2tpll cells were transfected with the Drosomycin or the Attacin reporter and treated, or not treated, with Ref(2)P dsRNA, and then they were either left untreated or induced with Cu2+ or LPS and the luciferase activity was measured. Consistent with the notion that Ref(2)P may be the Drosophila p62 homologue, the depletion of Ref(2)P leads to a severe reduction of the activation of the Drosomycin but not the Attacin promoter (Fig. 7). In addition, when Drosomycin and Diptericin mRNA levels were determined in Ref(2)P-depleted cells, it was clear that the induction of Drosomycin transcription by Torso-Pelle was significantly reduced whereas that of Diptericin by LPS was not affected (Fig. 8A). Of note, the down-regulation of Ref(2)P by RNAi promotes the release of DaPKC from a Triton-soluble membrane fraction (Fig. 8B), consistent with previously published evidence on the localization of p62 in mammalian cells (28).



View larger version (35K):
[in this window]
[in a new window]
  		FIG. 7. Ref(2)P is required for the activation of the Drosomycin promoter. S2tpll cells were (RNAi) or were not (Mock) transfected with Ref(2)P dsRNA along with either Drosomycin or Attacin luciferase reporter vectors, after which cells were stimulated (black bars) with Cu2+ (for the Drosomycin promoter) or LPS (for the Attacin promoter) or were left unstimulated (white bars), and the luciferase (Luc.) activities of cell extracts were determined. Results are the means ± SD of results from three independent experiments with duplicate incubations. A representative RT-PCR gel for Ref(2)P is shown below the graph.

 


View larger version (37K):
[in this window]
[in a new window]
  		FIG. 8. Ref(2)P is essential for Drosomycin transcription. (A) S2tpll cells were transfected with Ref(2)P dsRNA (RNAi) or were not transfected (Mock), after which they were stimulated with either Cu2+ (left panel) or LPS (right panel), and the levels of transcriptional activation of Drosomycin (left panel) and Diptericin (right panel) were determined by RT-PCR. The levels of Ref(2)P RNA were determined in parallel cell extracts by RT-PCR. (B) S2tpll cells were transfected or not transfected with Ref(2)P dsRNA, after which they were stimulated or not stimulated with Cu2+, and the localization of DaPKC in Triton-soluble membrane fractions was determined by immunoblot analysis. The results shown are representative of results from at least two other experiments.

 
Ref(2)P interacts with aPKC in vivo. In the next series of experiments, we determined whether there is a physical interaction between Ref(2)P and the aPKCs as has been demonstrated for p62 (29). Thus, 293 cells were transfected with a tagged version of the Ref(2)P expression plasmid, after which cell extracts were immunoprecipitated with either an irrelevant antibody or an anti-aPKC antibody to precipitate the endogenous aPKCs, and the associated Ref(2)P was determined with the corresponding anti-tag antibody. Interestingly, there is a clear association of aPKC and Ref(2)P in vivo (Fig. 9A). When the interaction between Ref(2)P and {alpha}PKC or {varepsilon}PKC was investigated in similar cotransfection experiments, it was clear that Ref(2)P, like p62, was unable to bind these PKC isotypes (data not shown). Of note, the binding of Ref(2)P to DaPKC in S2 cells was also detected (Fig. 9B).



View larger version (23K):
[in this window]
[in a new window]
  		FIG. 9. Ref(2)P interacts with aPKC in vivo. (A) Cultures of 293 cells were transfected with either an empty plasmid or an HA-tagged Ref(2)P expression vector, after which cell extracts (Ext) were immunoprecipitated with an irrelevant (-) or an anti-aPKC (+) antibody (Ab) and the immunoprecipitates (IP) were analyzed with an anti-HA antibody. (B) S2 cells were transfected with a Myc-tagged Ref(2)P expression plasmid along with either an empty vector or a DaPKC expression plasmid. Cell extracts were immunoprecipitated with an anti-aPKC antibody, and the immunoprecipitates were analyzed with an anti-Myc antibody. (C) Cultures of 293 cells were transfected with a Myc-tagged Ref(2)P expression plasmid along with either an empty vector or a Flag-tagged DTRAF2 expression plasmid. Cell extracts were immunoprecipitated with an anti-Flag antibody, and the immunoprecipitates were analyzed with an anti-Myc antibody. Aliquots corresponding to 1/10 of the amount of extracts (Ext) used for the immunoprecipitation were loaded into the gels and analyzed by immunoblotting with the corresponding antibodies. The results shown are representative of results from at least two other experiments. WB, Western blot.

 
Ref(2)P interacts with DTRAF2 in vivo. The physical and functional interaction between p62 and TRAF6 in mammalian cells is well established (29). Therefore, we next determined whether there is a physical and functional interaction between Ref(2)P and DTRAF2, the Drosophila TRAF6 homologue. Thus, 293 cells were transfected with a tagged version of the Ref(2)P expression plasmid with or without a tagged DTRAF2 expression vector, after which DTRAF2 was immunoprecipitated and the associated Ref(2)P was determined by immunoblotting with the corresponding anti-tag antibody. Results shown in Fig. 9C clearly demonstrate the in vivo association of Ref(2)P with DTRAF2. In order to investigate whether there is a functional interaction between both proteins, we sought to determine whether Ref(2)P cooperated with DTRAF2 to activate the Drosomycin promoter. Thus, S2 cells were first transfected with the Drosomycin promoter reporter construct as described above, along with a plasmid control or increasing amounts of a DTRAF2 expression plasmid. Results shown in Fig. 10A demonstrate that the expression of DTRAF2, like that of Ref(2)P (Fig. 6), is sufficient to activate the Drosomycin promoter, in agreement with previously reported results (32). More importantly, the ability of increasing concentrations of Ref(2)P to activate the Drosomycin promoter is synergistically enhanced by the expression of low levels of DTRAF2, which alone do not significantly activate this parameter (Fig. 10B). Collectively, these data indicate that there is a physical and functional interaction between both proteins, as has been reported for TRAF6 and p62 in mammalian cells.



View larger version (32K):
[in this window]
[in a new window]
  		FIG. 10. . Ref(2)P and DTRAF2 cooperate to activate the Drosomycin promoter. S2 cells were transfected with the Drosomycin luciferase reporter as described above, along with increasing amounts (1, 3, and 10 µg) of DTRAF2. (A) In addition, S2 cells were transfected with 1 µg of DTRAF2 expression vector either alone or with increasing amounts (1, 2, and 5 µg) of Ref(2)P expression plasmid (B). Results are the means ± SD of results from three independent experiments with duplicate incubations. Representative immunoblots for Ref(2)P and DTRAF2 performed with the corresponding anti-tag antibodies are shown below the graph.

 
Recombinant {zeta}PKC phosphorylates Dif in vitro. We have previously shown that mammalian {zeta}PKC is able to directly phosphorylate RelA in vitro (20). In order to address whether the Drosophila homologues of RelA can also be directly targeted by this kinase, recombinant bacterially expressed Dif was incubated either in the absence or in the presence of recombinant pure {zeta}PKC. The data shown in Fig. 11 demonstrate that {zeta}PKC is able to directly phosphorylate Dif in vitro.



View larger version (27K):
[in this window]
[in a new window]
  		FIG. 11. {zeta}PKC phosphorylates Dif in vitro. Recombinant pure GST-Dif or GST was incubated with pure recombinant {zeta}PKC, and the phosphorylation was determined as described in Materials and Methods. The results shown are representative of results from two other experiments.

 

   DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The involvement of the aPKCs in NF-{kappa}B activation has been extensively documented in a number of studies that used a large variety of experimental strategies (24). Most recently, the generation of a mouse with the {zeta}PKC isoform knocked out has demonstrated that this particular PKC isotype is required for NF-{kappa}B-dependent transcriptional activity (20). Thus, in embryonic fibroblasts from {zeta}PKC-/- cells, the activation of a {kappa}B-dependent reporter as well as the induction of {kappa}B-dependent transcripts was, although not completely inhibited, seriously impaired (20). However, the activation of the IKK complex or the nuclear translocation of NF-{kappa}B was not affected by the lack of {zeta}PKC in that cell system, indicating that {zeta}PKC, like T2K or GSK-3ß (2, 11, 43), appears to act, at least in embryonic fibroblasts, in the control of {kappa}B-dependent transcription at a level that is downstream of the translocation of NF-{kappa}B. However, in other tissues, such as lung, in which {zeta}PKC levels are much higher than in fibroblasts, the lack of {zeta}PKC also inhibits IKK activation and the nuclear translocation of NF-{kappa}B (20). Therefore, it seems that in cells in which {zeta}PKC levels are very low, this PKC isoform plays an essential role in NF-{kappa}B-dependent transcriptional activation that cannot be compensated for by {lambda}/{iota}PKC, which is ubiquitously and abundantly expressed (20); in cells where {zeta}PKC levels are higher, it may function upstream of the IKK complex, possibly as an IKK kinase (19). This is reminiscent of, for example, the cell type-dependent role played by IKK{alpha} in NF-{kappa}B signaling. Thus, IKK{alpha}-deficient fibroblasts show a nearly intact IKK activity in response to tumor necrosis factor alpha (13, 17, 21) but have dramatically impaired activation of {kappa}B-dependent transcription (35) due to a lack of p65 activation. However, in mammary epithelial cells (3), IKK{alpha} is critical for I{kappa}B degradation and NF-{kappa}B activation in response to RANK signaling.

Drosophila appears to be an ideal system in which to determine the primary role of the aPKCs in NF-{kappa}B signal transduction because it encodes only one aPKC isoform. According to the data presented here, DaPKC is selectively required for the innate immune Toll-signaling pathway, acting downstream of the translocation of Dorsal and Dif and playing a critical role in the induction of the antimicrobial peptide gene for Drosomycin, which is a typical NF-{kappa}B-dependent process. Therefore, it can be argued that the primary role of the aPKCs, particularly that of {zeta}PKC in higher eukaryotic cells, is to somehow control the transcriptional activity of NF-{kappa}B through a still not completely understood mechanism that most likely involves the direct phosphorylation of RelA (20) and Dif (this study). Interestingly, in Drosophila it is well documented that the phosphorylation of Dorsal is required not only for its transcriptional activity but also for its nuclear translocation (1, 8). We did not observe, in the DaPKC-depleted cells, a strong inhibition of Dorsal or Dif nuclear translocation, which suggests that the role of DaPKC is independent of the previously characterized role for Dorsal phosphorylation in regulating nuclear translocation. Based on experiments in mammalian systems, which demonstrate that p65 transcriptional activity must be stimulated by phosphorylation (31), it is possible that the residues that control the transcriptional activities of both Dorsal and Dif are different from those controlling the nuclear import of the protein. It is also possible that DaPKC-mediated phosphorylation has a subtle, yet important, role in the nuclear translocation of Dif and/or Dorsal. Future studies will address this important issue.

The data presented here also demonstrate that Ref(2)P is most likely the functional homologue of p62 in Drosophila (Fig. 12). We show that like p62, Ref(2)P interacts physically with the aPKCs. Therefore, it appears that the p62-aPKC signaling module, like the Par/aPKC complex, is highly conserved. Importantly, we also demonstrate a functional role of Ref(2)P in Toll signaling. Thus, the ectopic expression of Ref(2)P is capable by itself of activating the Drosomycin promoter. More interestingly, its depletion severely impairs the Toll pathway (Drosomycin induction) but not the LPS pathway (Attacin induction). Thus, the Ref(2)P/DaPKC complex is critical for Toll signaling.



View larger version (22K):
[in this window]
[in a new window]
  		FIG. 12. Innate immunity pathways in Drosophila. Triggering the antifungal pathway leads to the activation of Drosomycin transcription. This cascade is initiated when Spätzle binds Toll, recruiting the adapters DMyD88, Pelle, Tube, and possibly DTRAF2. The latter interacts with Ref(2)P, which also binds DaPKC. Both Ref(2)P and DaPKC are essential for Toll-induced Drosomocyn expression, but they are not required for Cactus degradation. Instead, we propose that they stimulate Dif and/or Dorsal transcriptional activity. A parallel pathway is triggered by gram-negative bacteria, which leads to the activation of Diptericin and Attacin transcription. This cascade signals through the receptor peptidoglycan recognition protein (PGRP)-LC and the adapter Imd and activates a Drosophila IKK complex. The D. melanogaster IKK complex regulates Relish endoproteolytic activation, via the caspase Dredd, and thus controls Diptericin expression. In parentheses are shown the names of the mammalian homologues of Pelle, DTRAF2, Ref(2)P, Dorsal, Dif, Imd, and Relish.

 
The results presented here also demonstrate that, similar to the p62-TRAF6 connection in mammals, Ref(2)P and DTRAF2 physically and functionally interact. Together with the results demonstrating that DaPKC and Ref(2)P are essential for a downstream event in the Toll-signaling pathway, this suggests that a putative Ref(2)P/DaPKC/DTRAF2 complex might function in the signal-induced stimulation of Dif or Dorsal transcriptional activity. In this regard, it is noteworthy that recent results suggest that TRAF6, in addition to its role in IKK recruitment and activation, may also be involved in the control of RelA transcriptional activity (15). However, the role of DTRAF2 in Toll signaling requires further investigation, as the effect of inhibiting (or mutating) DTRAF2 has not yet been reported. Further studies will also address the precise mechanism whereby DaPKC controls the Toll pathway. The data presented here clearly establish the conserved role of the homologue of the p62/aPKC cassette in NF-{kappa}B signaling in Drosophila.


   ACKNOWLEDGMENTS
 
This work was supported by grants SAF1999-0053, 2FD97-1429, and SAF2000-0175 from MCYT and by 08.1/0060/2000 from CAM and has benefited from an institutional grant from Fundación Ramón Areces to the CBM. A.A. is a fellow from the Ministerio de Ciencia y Tecnología. J.M. is the recipient of Ir Ayuda de la Fundación Juan March a la Investigación Básica.

We thank Svenja Stoven and Dan Hultmark for reagents and for critically reading the manuscript.


   FOOTNOTES
 
* Corresponding author. Mailing address: CBMSO, Universidad Autónoma, Canto Blanco, 28049 Madrid, Spain. Phone: 34-913978039. Fax: 34-917616184. E-mail: jmoscat{at}cbm.uam.es. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
1. Bergmann, A., D. Stein, R. Geisler, S. Hagenmaier, B. Schmid, N. Fernandez, B. Schnell, and C. Nusslein-Volhard. 1996. A gradient of cytoplasmic Cactus degradation establishes the nuclear localization gradient of the dorsal morphogen in Drosophila. Mech. Dev. 60:109-123.[CrossRef][Medline]

2. Bonnard, M., C. Mirtsos, S. Suzuki, K. Graham, J. Huang, M. Ng, A. Itie, A. Wakeham, A. Shahinian, W. J. Henzel, A. J. Elia, W. Shillinglaw, T. W. Mak, Z. Cao, and W. C. Yeh. 2000. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19:4976-4985.[CrossRef][Medline]

3. Cao, Y., G. Bonizzi, T. N. Seagroves, F. R. Greten, R. Johnson, E. V. Schmidt, and M. Karin. 2001. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107:763-775.[CrossRef][Medline]

4. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D. V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383:443-446.[CrossRef][Medline]

5. Contamine, D., A. M. Petitjean, and M. Ashburner. 1989. Genetic resistance to viral infection: the molecular cloning of a Drosophila gene that restricts infection by the rhabdovirus sigma. Genetics 123:525-533.[Abstract/Free Full Text]

6. Dezelee, S., F. Bras, D. Contamine, M. Lopez-Ferber, D. Segretain, and D. Teninges. 1989. Molecular analysis of ref(2)P, a Drosophila gene implicated in sigma rhabdovirus multiplication and necessary for male fertility. EMBO J. 8:3437-3446.[Medline]

7. Diaz-Meco, M. T., and J. Moscat. 2001. MEK5, a new target of the atypical protein kinase C isoforms in mitogenic signaling. Mol. Cell. Biol. 21:1218-1227.[Abstract/Free Full Text]

8. Drier, E. A., S. Govind, and R. Steward. 2000. Cactus-independent regulation of Dorsal nuclear import by the ventral signal. Curr. Biol. 10:23-26.[CrossRef][Medline]

9. Dushay, M. S., B. Asling, and D. Hultmark. 1996. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc. Natl. Acad. Sci. USA 93:10343-10347.[Abstract/Free Full Text]

10. Fernandez, N. Q., J. Grosshans, J. S. Goltz, and D. Stein. 2001. Separable and redundant regulatory determinants in Cactus mediate its dorsal group dependent degradation. Development 128:2963-2974.[Abstract/Free Full Text]

11. Hoeflich, K. P., J. Luo, E. A. Rubie, M. S. Tsao, O. Jin, and J. R. Woodgett. 2000. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406:86-90.[CrossRef][Medline]

12. Horng, T., and R. Medzhitov. 2001. Drosophila MyD88 is an adapter in the Toll signaling pathway. Proc. Natl. Acad. Sci. USA 98:12654-12658.[Abstract/Free Full Text]

13. Hu, Y., V. Baud, T. Oga, K. I. Kim, K. Yoshida, and M. Karin. 2001. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 410:710-714.[CrossRef][Medline]

14. Imler, J. L., and J. A. Hoffmann. 2001. Toll receptors in innate immunity. Trends Cell Biol. 11:304-311.[CrossRef][Medline]

15. Jefferies, C., A. Bowie, G. Brady, E.-L. Cooke, X. Li, and L. A. J. O'Neill. 2001. Transactivation by the p65 subunit of NF-{kappa}B in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1. Mol. Cell. Biol. 21:4544-4552.[Abstract/Free Full Text]

16. Joberty, G., C. Petersen, L. Gao, and I. G. Macara. 2000. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat. Cell Biol. 2:531-539.[CrossRef][Medline]

17. Karin, M. 1999. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274:27339-27342.[Free Full Text]

18. Khush, R. S., F. Leulier, and B. Lemaitre. 2001. Drosophila immunity: two paths to NF-kappaB. Trends Immunol. 22:260-264.[CrossRef][Medline]

19. Lallena, M.-J., M. T. Diaz-Meco, G. Bren, C. V. Payá, and J. Moscat. 1999. Activation of I{kappa}B kinase ß by protein kinase C isoforms. Mol. Cell. Biol. 19:2180-2188.[Abstract/Free Full Text]

20. Leitges, M., L. Sanz, P. Martin, A. Duran, U. Braun, J. F. Garcia, F. Camacho, M. T. Diaz-Meco, P. D. Rennert, and J. Moscat. 2001. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol. Cell 8:771-780.[CrossRef][Medline]

21. Li, Q., G. Estepa, S. Memet, A. Israel, and I. M. Verma. 2000. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 14:1729-1733.[Abstract/Free Full Text]

22. Lin, D., A. S. Edwards, J. P. Fawcett, G. Mbamalu, J. D. Scott, and T. Pawson. 2000. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat. Cell Biol. 2:540-547.[CrossRef][Medline]

23. Lomaga, M. A., W. C. Yeh, I. Sarosi, G. S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, A. van der Heiden, A. Itie, A. Wakeham, W. Khoo, T. Sasaki, Z. Cao, J. M. Penninger, C. J. Paige, D. L. Lacey, C. R. Dunstan, W. J. Boyle, D. V. Goeddel, and T. W. Mak. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1015-1024.[Abstract/Free Full Text]

24. Moscat, J., and M. T. Diaz-Meco. 2000. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep. 1:399-403.[CrossRef][Medline]

25. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484-496.[Abstract]

26. Ponting, C. P., T. Ito, J. Moscat, M. T. Diaz-Meco, F. Inagaki, and H. Sumimoto. 2002. OPR, PC and AID: all in the PB1 family. Trends Biochem. Sci. 27:10.[CrossRef][Medline]

27. Qiu, R. G., A. Abo, and G. Steven Martin. 2000. A human homolog of the C. elegans polarity determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell transformation. Curr. Biol. 10:697-707.[CrossRef][Medline]

28. Sanchez, P., G. De Carcer, I. V. Sandoval, J. Moscat, and M. T. Diaz-Meco. 1998. Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol. Cell. Biol. 18:3069-3080.[Abstract/Free Full Text]

29. Sanz, L., M. T. Diaz-Meco, H. Nakano, and J. Moscat. 2000. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J. 19:1576-1586.[CrossRef][Medline]

30. Sanz, L., P. Sanchez, M. J. Lallena, M. T. Diaz-Meco, and J. Moscat. 1999. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 18:3044-3053.[CrossRef][Medline]

31. Schmitz, M. L., S. Bacher, and M. Kracht. 2001. I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem. Sci. 26:186-190.[CrossRef][Medline]

32. Shen, B., H. Liu, E. Y. Skolnik, and J. L. Manley. 2001. Physical and functional interactions between Drosophila TRAF2 and Pelle kinase contribute to Dorsal activation. Proc. Natl. Acad. Sci. USA 98:8596-8601.[Abstract/Free Full Text]

33. Silverman, N., and T. Maniatis. 2001. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15:2321-2342.[Free Full Text]

34. Silverman, N., R. Zhou, S. Stoven, N. Pandey, D. Hultmark, and T. Maniatis. 2000. A Drosophila IkappaB kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev. 14:2461-2471.[Abstract/Free Full Text]

35. Sizemore, N., N. Lerner, N. Dombrowski, H. Sakurai, and G. R. Stark. 2002. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J. Biol. Chem. 277:3863-3869.[Abstract/Free Full Text]

36. Stoven, S., I. Ando, L. Kadalayil, Y. Engstrom, and D. Hultmark. 2000. Activation of the Drosophila NF-kappaB factor Relish by rapid endoproteolytic cleavage. EMBO Rep. 1:347-352.[CrossRef][Medline]

37. Suzuki, A., T. Yamanaka, T. Hirose, N. Manabe, K. Mizuno, M. Shimizu, K. Akimoto, Y. Izumi, T. Ohnishi, and S. Ohno. 2001. Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J. Cell Biol. 152:1183-1196.[Abstract/Free Full Text]

38. Tauszig-Delamasure, S., H. Bilak, M. Capovilla, J. A. Hoffmann, and J. L. Imler. 2002. Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections. Nat. Immunol. 3:91-97.[CrossRef][Medline]

39. Wayne, M. L., D. Contamine, and M. Kreitman. 1996. Molecular population genetics of ref(2)P, a locus which confers viral resistance in Drosophila. Mol. Biol. Evol. 13:191-199.[Abstract]

40. Wodarz, A., A. Ramrath, A. Grimm, and E. Knust. 2000. Drosophila atypical protein kinase C associates with Bazooka and controls polarity of epithelia and neuroblasts. J. Cell Biol. 150:1361-1374.[Abstract/Free Full Text]

41. Wooten, M. W., M. L. Seibenhener, V. Mamidipudi, M. T. Diaz-Meco, P. A. Barker, and J. Moscat. 2001. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. J. Biol. Chem. 276:7709-7712.[Abstract/Free Full Text]

42. Wyers, F., A. M. Petitjean, P. Dru, P. Gay, and D. Contamine. 1995. Localization of domains within the Drosophila Ref(2)P protein involved in the intracellular control of sigma rhabdovirus multiplication. J. Virol. 69:4463-4470.[Abstract]

43. Yin, L., L. Wu, H. Wesche, C. D. Arthur, J. M. White, D. V. Goeddel, and R. D. Schreiber. 2001. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291:2162-2165.[Abstract/Free Full Text]

Molecular and Cellular Biology, December 2002, p. 8787-8795, Vol. 22, No. 24
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.24.8787-8795.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avila, A.
Right arrow Articles by Moscat, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avila, A.
Right arrow Articles by Moscat, J.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals